Richard A. Gonzalez
Chairman
AbbVie Inc. (ABBV)Equibles does not estimate personal net worth.
Get an email with a short summary when AbbVie Inc. publishes a filing, an earnings call transcript or a press release.
Get ABBV alertsAbout Richard A. Gonzalez
Richard A. Gonzalez is recorded as Chairman at AbbVie Inc. (ABBV) since July 1, 2024. AbbVie Inc. reported in an 8-K filed May 13, 2025 that Richard A. Gonzalez retired as director, effective July 1, 2025. AbbVie Inc. reported in an 8-K filed February 14, 2025 that Richard A. Gonzalez retired as Chairman, effective July 1, 2025. AbbVie Inc. reported in an 8-K filed February 20, 2024 that Richard A. Gonzalez was appointed Executive Chairman of the Board of Directors, effective July 1, 2024. Equibles holds 4 filed executive changes naming Richard A. Gonzalez; each is listed under recent activity with its source filing. The proxy statement of AbbVie Inc. reports total compensation of $21,610,598 for Richard A. Gonzalez in fiscal 2019, including a base salary of $1,650,000. Disclosed compensation is on record for 3 fiscal years. AbbVie Inc. is classified in the Drug Manufacturers - General industry within the Healthcare sector. Other leadership on record at AbbVie Inc. includes Robert A. Michael (CEO, Chairman, CFO, COO and Board Member), Scott T. Reents (CFO), Dr. John M. Carethers (Board Member) and 4 others.
“The Board also determined that the size of the Board will decrease from fifteen directors to thirteen directors upon the retirement of Richard A. Gonzalez and Glenn F. Tilton from the Board, effective July 1, 2025.”
“Mr. Gonzalez, who has served as Chairman since the Company's formation in 2013, will retire from the Board, effective July 1, 2025.”
Affiliation history
-
Current
2024-07-01–present
-
2024-07-01–2025-07-01
Company network
Leadership on record at AbbVie Inc.
- Robert A. Michael CEO, Chairman, CFO, COO, Board Member
- Scott T. Reents CFO
- Dr. John M. Carethers Board Member
- Jennifer Davis Board Member
- Susan Quaggin Board Member
- Thomas Freyman Board Member
- Thomas J. Falk Board Member
Executive compensation
Compensation components disclosed in company proxy statements. Amounts are nominal USD; total is the company-reported figure.
| Fiscal year | Company | Role | Salary | Total |
|---|---|---|---|---|
| 2019 | AbbVie Inc. (ABBV) | Chairman of the Board and Chief Executive Officer | $1,650,000 | $21,610,598 |
| 2018 | AbbVie Inc. (ABBV) | Chairman of the Board and Chief Executive Officer | $1,650,000 | $21,283,587 |
| 2017 | AbbVie Inc. (ABBV) | Chairman of the Board and Chief Executive Officer | $1,638,462 | $22,625,243 |